Analysts Conflicted on These Healthcare Names: Dexcom (DXCM) and Fate Therapeutics (FATE)
at www.tipranks.com (Mon, 5-Oct 7:20 AM)
Dexcom Lifts Full-Year Outlook as Q2 Profitability and Expansion Accelerate: Operating Margins Jump, Guidance Raised
Market Chameleon (Fri, 31-Jul 11:46 AM)
